Jugular Foramen Paraganglioma
7th March, 2026, 07:30 - 08:30
Pacific A
This session will cover the emerging importance of genetic testing, special considerations when managing children and young adults, and the increasing role of stereotactic radiation in tumor management. The surgical management of patients with paragangliomas present a myriad of pre-operative and intra-operative decisions all tailored to a specific patient. Through case presentation and discussion the session will focus on these key decision points and techniques experts find helpful in achieving excellent outcomes.
Objectives
At the conclusion of this session, attendees will be able to:
- Articulate why genetic testing is imperative and how it is used to drive treatment decisions.
- Select when stereotactic radiosurgery is the commonly preferred primary treatment choice.
- Describe the various standard and emerging methods of adjunct endovascular interventions.
- Choose a degree of surgical resection based on goals and prepare for technically challenging surgical steps.
Current Schedule
As a faculty member of this session, you can click on names to email the speaker. Phone numbers are below names
Speaker | Title | Role | Times |
---|---|---|---|
Mohamed Labib 2145028986 |
Moderator | - | |
Colin Driscoll 507-284-4065 x2 |
Moderator | - | |
Aloysio Augusto Tahan de Campos Netto +5511999821330 |
Panelist | - | |
Duarte Candido |
Panelist | - | |
Richard Gurgel 801-585-1280 |
Paragangliomas in Children and Young Adults – Special Considerations | Speaker | 7:30 am - 7:40 am |
Douglas Kondziolka 646-501-2360 |
Why Not Treat All Temporal Bone/Jugular Foramen Paraganglioma with Radiation? | Speaker | 7:40 am - 7:50 am |
Seilesh Babu 248-865-4135 |
Why Not Take It All Out? What Drives Surgeons to Choose Subtotal or Partial Resection | Speaker | 7:50 am - 8:00 am |
|
Case Discussion – What the Experts Do | 8:00 am - 8:30 am |